English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Relias
Trending
+
Pharmaceuticals
Patient Daily
| Feb 3, 2026
Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+
Pharmaceuticals
Patient Daily
| Feb 5, 2026
FDA lifts hold on Intellia's phase III ATTR gene editing trial
+
Pharmaceuticals
Patient Daily
| Feb 4, 2026
Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor
+
Pharmaceuticals
Patient Daily
| Feb 4, 2026
Palbociclib shows promise extending survival in HR+, HER2+ metastatic breast cancer
No Results
